Benitec Biopharma Equity 2024

Benitec Biopharma Aktienanalyse

What does Benitec Biopharma do?

Benitec Biopharma Inc is a biopharmaceutical company based in the United States that focuses on developing groundbreaking therapies for the treatment of serious diseases. The company was founded in 1995 and is headquartered in Hayward, California. Benitec Biopharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Benitec Biopharma's Equity

Benitec Biopharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Benitec Biopharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Benitec Biopharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Benitec Biopharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Benitec Biopharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Benitec Biopharma stock

What is the equity of Benitec Biopharma this year?

Benitec Biopharma has equity of 200,000 USD this year.

What was the equity of Benitec Biopharma compared to the previous year?

The equity of Benitec Biopharma has increased/decreased by -93.06% decreased compared to the previous year.

What impact does a high equity have on investors of Benitec Biopharma?

A high equity is advantageous for investors of Benitec Biopharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Benitec Biopharma?

A low equity can be a risk for investors of Benitec Biopharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Benitec Biopharma affect the company?

An increase in equity of Benitec Biopharma can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Benitec Biopharma affect the company?

A reduction in equity of Benitec Biopharma can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Benitec Biopharma?

Some factors that can affect the equity of Benitec Biopharma include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Benitec Biopharma so important for investors?

The equity of Benitec Biopharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Benitec Biopharma take to change the equity?

To change equity, Benitec Biopharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Benitec Biopharma pay?

Over the past 12 months, Benitec Biopharma paid a dividend of 0.04 USD . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Benitec Biopharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Benitec Biopharma?

The current dividend yield of Benitec Biopharma is 0.49 %.

When does Benitec Biopharma pay dividends?

Benitec Biopharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Benitec Biopharma?

Benitec Biopharma paid dividends every year for the past 0 years.

What is the dividend of Benitec Biopharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Benitec Biopharma located?

Benitec Biopharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Benitec Biopharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Benitec Biopharma from 6/8/2018 amounting to 0.003 USD, you needed to have the stock in your portfolio before the ex-date on 6/1/2018.

When did Benitec Biopharma pay the last dividend?

The last dividend was paid out on 6/8/2018.

What was the dividend of Benitec Biopharma in the year 2023?

In the year 2023, Benitec Biopharma distributed 0 USD as dividends.

In which currency does Benitec Biopharma pay out the dividend?

The dividends of Benitec Biopharma are distributed in USD.